Dr. Quan Dong Nguyen presents interim data from the phase 3 DRAGON study on a potential first therapy for adolescent Stargardt disease.
Quan Dong Nguyen, MD, MSc, FAAO, FARVO, FASRS
Advertisement
Articles by Quan Dong Nguyen, MD, MSc, FAAO, FARVO, FASRS
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
Timely interventions can protect vision in patients with GA
2
FLORetina 2025: Long-term follow-up in pediatric gene therapy
3
Evolving Therapeutic Strategies with Next-Generation Anti-VEGF Agents in Retinal Vascular Diseases
4
Aviceda Therapeutics reports positive phase 2b SIGLEC results for AVD-104 in geographic atrophy
5